Want to see HK:0911 full AI Analyst Report?
Top Page
Qianhai Health Holdings Ltd.
(0911)
Select Model
Select Model
Rating:61Neutral
Price Target:
HK$0.33
▲(18.57% Upside)
Action:Reiterated
Date:09/22/26
The score is driven primarily by improved financial performance and low balance-sheet risk (turnaround to positive earnings and stronger cash flow, with minimal leverage). However, the overall rating is held back by very weak technical momentum (below major moving averages with negative MACD and oversold indicators) and only moderate valuation support (P/E ~15 with no dividend yield data).
Positive Factors
Return to Profitability
The return to positive net income and operating profit marks a meaningful improvement in the earnings base after prior losses. If maintained, profitability can support internal funding, improve resilience, and provide a more durable foundation for future operations.
Negative Factors
Volatile Revenue and Earnings Recovery
The sharp revenue rebound is encouraging but follows consecutive declines and a volatile multi-year record, making the recovery less predictable. Continued fluctuations could disrupt operating planning, weaken confidence in sustainable growth, and make future profitability more sensitive to changes in demand.
Read all positive and negative factors
Positive Factors
Negative Factors
Return to Profitability
The return to positive net income and operating profit marks a meaningful improvement in the earnings base after prior losses. If maintained, profitability can support internal funding, improve resilience, and provide a more durable foundation for future operations.
Read all positive factors
Qianhai Health Holdings Ltd. (0911) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$53.38M
Dividend Yield121.95%
Average Volume (3M)28.24K
Price to Earnings (P/E)13.3
Beta (1Y)0.06
Revenue Growth-18.16%
EPS GrowthN/A
CountryHK
Employees19
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)0.02
Shares Outstanding169,445,000
10 Day Avg. Volume25,197
30 Day Avg. Volume28,243
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.12
Price to Sales (P/S)0.07
P/FCF Ratio1.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Qianhai Health Holdings Ltd. Business Overview & Revenue Model
Company Description
Qianhai Health Holdings Limited (0911.HK) functions as an investment holding company primarily focused on the distribution of health products and electronic components within Hong Kong. Its operations are structured into two main divisions: Health...
Qianhai Health Holdings Ltd. Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
84
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 453.03M | 677.12M | 519.70M | 961.29M | 1.96B | 283.40M |
| Gross Profit | 15.82M | 22.26M | 29.67M | -35.60M | 76.48M | 16.04M |
| EBITDA | 5.29M | 7.19M | 16.32M | -50.23M | -231.24M | 2.06M |
| Net Income | 4.01M | 5.94M | 1.31M | -52.70M | -233.70M | -888.00K |
Balance Sheet | ||||||
| Total Assets | 441.43M | 408.39M | 407.31M | 478.12M | 534.43M | 738.63M |
| Cash, Cash Equivalents and Short-Term Investments | 17.88M | 61.38M | 23.51M | 19.52M | 1.64M | 2.47M |
| Total Debt | 107.00K | 424.00K | 1.03M | 487.00K | 1.19M | 7.83M |
| Total Liabilities | 47.39M | 17.19M | 21.74M | 94.00M | 97.73M | 68.09M |
| Stockholders Equity | 394.05M | 391.20M | 385.57M | 384.11M | 436.70M | 670.53M |
Cash Flow | ||||||
| Free Cash Flow | -8.64M | 38.78M | 4.19M | 857.00K | -5.26M | -44.19M |
| Operating Cash Flow | -8.64M | 38.80M | 4.20M | 857.00K | -5.26M | -44.18M |
| Investing Cash Flow | -3.00K | -14.00K | 246.00K | 17.77M | 12.34M | 46.84M |
| Financing Cash Flow | -648.00K | -648.00K | -712.00K | -743.00K | -7.91M | -16.56M |
Qianhai Health Holdings Ltd. Technical Analysis
Negative
0.28
Price Trends
0.41
Negative
0.53
Negative
0.48
Negative
Market Momentum
-0.03
Negative
28.04
Positive
5.17
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0911, the sentiment is Negative. The current price of 0.28 is below the 20-day moving average (MA) of 0.35, below the 50-day MA of 0.41, and below the 200-day MA of 0.48, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 28.04 is Positive, neither overbought nor oversold. The STOCH value of 5.17 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0911.
Qianhai Health Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$1.78B | 6.19 | 13.26% | 9.67% | -0.47% | -0.40% | |
61 Neutral | HK$53.38M | 13.29 | 1.02% | 121.95% | -18.16% | ― | |
54 Neutral | HK$147.90M | -0.13 | -154.56% | ― | -7.12% | -523.61% | |
53 Neutral | HK$401.18M | 100.00 | 0.34% | 84.69% | -8.30% | -44.44% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
43 Neutral | HK$123.04M | -4.04 | -21.66% | 0.48% | -6.71% | 43.14% | |
42 Neutral | HK$191.35M | -2.73 | -14.55% | 1.13% | 12.89% | -2.56% |
* Healthcare Sector Average
HK:0911
Qianhai Health Holdings Ltd.
0.32
-0.03
-7.35%
HK:0858
Extrawell Pharmaceutical Holdings Limited
0.05
-0.04
-44.57%
HK:0455
Tianda Pharmaceuticals Ltd.
0.09
-0.05
-34.07%
HK:0897
Wai Yuen Tong Medicine Holdings Limited
0.36
-0.10
-21.74%
HK:1498
PuraPharm Corp. Ltd.
0.23
-0.19
-45.24%
HK:2633
Jacobson Pharma Corporation Limited
0.94
-0.42
-30.74%
Qianhai Health Holdings Ltd. Corporate Events
Qianhai Health Shifts Hong Kong Principal Office to Causeway Bay
Sep 18, 2026
Qianhai Health Holdings Limited has announced a change to its principal place of business in Hong Kong, which will move to Room 1622, 16/F, Leighton Centre, 77 Leighton Road, Causeway Bay, effective 22 September 2026. The company emphasized that i...
Qianhai Health’s Interim Profit Holds Up Despite Sharp Revenue Drop
Aug 12, 2026
Qianhai Health Holdings reported unaudited interim revenue of HK$116.76 million for the six months ended 30 June 2026, down sharply from HK$340.85 million a year earlier, with gross profit falling to HK$7.71 million from HK$14.16 million as cost o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.